JP2009185061A5 - - Google Patents

Download PDF

Info

Publication number
JP2009185061A5
JP2009185061A5 JP2009115044A JP2009115044A JP2009185061A5 JP 2009185061 A5 JP2009185061 A5 JP 2009185061A5 JP 2009115044 A JP2009115044 A JP 2009115044A JP 2009115044 A JP2009115044 A JP 2009115044A JP 2009185061 A5 JP2009185061 A5 JP 2009185061A5
Authority
JP
Japan
Prior art keywords
drug delivery
transdermal drug
fentanyl
acrylate
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009115044A
Other languages
English (en)
Japanese (ja)
Other versions
JP4976445B2 (ja
JP2009185061A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009185061A publication Critical patent/JP2009185061A/ja
Publication of JP2009185061A5 publication Critical patent/JP2009185061A5/ja
Application granted granted Critical
Publication of JP4976445B2 publication Critical patent/JP4976445B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009115044A 2000-09-29 2009-05-11 フェンタニルの経皮デリバリのための組成物 Expired - Lifetime JP4976445B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23697300P 2000-09-29 2000-09-29
US60/236,973 2000-09-29
US28401701P 2001-04-16 2001-04-16
US60/284,017 2001-04-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002530047A Division JP2004513890A (ja) 2000-09-29 2001-09-27 フェンタニルの経皮デリバリのための組成物

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010015817A Division JP2010100650A (ja) 2000-09-29 2010-01-27 フェンタニルの経皮デリバリのための組成物
JP2010279739A Division JP5425751B2 (ja) 2000-09-29 2010-12-15 フェンタニルの経皮デリバリのための組成物

Publications (3)

Publication Number Publication Date
JP2009185061A JP2009185061A (ja) 2009-08-20
JP2009185061A5 true JP2009185061A5 (enExample) 2010-03-18
JP4976445B2 JP4976445B2 (ja) 2012-07-18

Family

ID=26930280

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2002530047A Pending JP2004513890A (ja) 2000-09-29 2001-09-27 フェンタニルの経皮デリバリのための組成物
JP2009115044A Expired - Lifetime JP4976445B2 (ja) 2000-09-29 2009-05-11 フェンタニルの経皮デリバリのための組成物
JP2010015817A Withdrawn JP2010100650A (ja) 2000-09-29 2010-01-27 フェンタニルの経皮デリバリのための組成物
JP2010279739A Expired - Lifetime JP5425751B2 (ja) 2000-09-29 2010-12-15 フェンタニルの経皮デリバリのための組成物
JP2013200504A Withdrawn JP2013256536A (ja) 2000-09-29 2013-09-26 フェンタニルの経皮デリバリのための組成物
JP2015247296A Expired - Lifetime JP6437908B2 (ja) 2000-09-29 2015-12-18 フェンタニルの経皮デリバリのための組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002530047A Pending JP2004513890A (ja) 2000-09-29 2001-09-27 フェンタニルの経皮デリバリのための組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2010015817A Withdrawn JP2010100650A (ja) 2000-09-29 2010-01-27 フェンタニルの経皮デリバリのための組成物
JP2010279739A Expired - Lifetime JP5425751B2 (ja) 2000-09-29 2010-12-15 フェンタニルの経皮デリバリのための組成物
JP2013200504A Withdrawn JP2013256536A (ja) 2000-09-29 2013-09-26 フェンタニルの経皮デリバリのための組成物
JP2015247296A Expired - Lifetime JP6437908B2 (ja) 2000-09-29 2015-12-18 フェンタニルの経皮デリバリのための組成物

Country Status (24)

Country Link
US (18) US20020119187A1 (enExample)
EP (6) EP1322299B1 (enExample)
JP (6) JP2004513890A (enExample)
KR (1) KR20030043978A (enExample)
CN (1) CN100490805C (enExample)
AR (1) AR037081A1 (enExample)
AT (1) ATE449599T1 (enExample)
AU (2) AU1531502A (enExample)
BR (1) BR0114315A (enExample)
CA (1) CA2423836C (enExample)
CY (1) CY1118798T1 (enExample)
CZ (1) CZ305119B6 (enExample)
DE (1) DE60140616D1 (enExample)
DK (2) DK2158905T3 (enExample)
EE (1) EE05391B1 (enExample)
ES (2) ES2407987T3 (enExample)
HU (1) HUP0302926A3 (enExample)
IL (1) IL154857A0 (enExample)
MX (1) MXPA03002548A (enExample)
NO (1) NO333525B1 (enExample)
NZ (1) NZ524767A (enExample)
PL (1) PL360708A1 (enExample)
PT (2) PT2153828T (enExample)
WO (1) WO2002026217A2 (enExample)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
JP2004509222A (ja) * 2000-09-19 2004-03-25 ナショナル　スターチ　アンド　ケミカル　インベストメント　ホールディング　コーポレイション 経皮薬物送達システムにおいて有用な非反応型接着剤
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE20220982U1 (de) * 2001-03-16 2004-11-25 Alza Corp., Mountain View Transdermal-Pflaster zum Verabreichen von Fentanyl
JP5354763B2 (ja) * 2001-03-16 2013-11-27 アルザ・コーポレーシヨン フェンタニルを投与するための経皮的張り付け剤
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
AU2007202273B2 (en) * 2001-08-24 2009-11-05 Lts Lohmann Therapie - Systeme Ag Transdermal therapeutic system containing fentanyl or related substance
WO2003090729A1 (en) * 2002-04-23 2003-11-06 Alza Corporation Transdermal analgesic systems with reduced abuse potential
AR033748A1 (es) 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
US20060039960A1 (en) * 2002-05-28 2006-02-23 Cordes Guenter Plaster containing fentanyl
DE10223835A1 (de) * 2002-05-28 2003-12-11 Labtec Gmbh Pflaster, enthaltend Fentanylum
EP1386604A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
AU2004235794B8 (en) 2003-04-30 2009-07-23 Purdue Pharma L.P. Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
EP1684734A2 (en) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) * 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
BRPI0509901A (pt) * 2004-04-13 2007-08-07 Alza Corp aparelho e método para liberação transdérmica de agentes com base em fentanila
CN101005833A (zh) * 2004-08-20 2007-07-25 3M创新有限公司 具有半透明保护膜的透皮药物递送装置
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP1814531B1 (en) 2004-10-21 2010-06-16 Durect Corporation Transdermal delivery systems
ATE539740T1 (de) 2005-06-10 2012-01-15 3M Innovative Properties Co Verfahren zur handhabung von klebenden laminatabschnitten
WO2007035940A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal norelgestromin delivery system
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
WO2007035939A2 (en) 2005-09-23 2007-03-29 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
JP5114042B2 (ja) * 2005-10-19 2013-01-09 ニプロパッチ株式会社 貼付剤、及び貼付剤の製造方法
US7888422B2 (en) * 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
GB0615136D0 (en) * 2006-07-29 2006-09-06 Univ Edinburgh Induction of analgesia in neuropathic pain
JP5227041B2 (ja) * 2007-02-28 2013-07-03 日東電工株式会社 薬物含有貼付製剤
CN100465201C (zh) * 2007-04-25 2009-03-04 上海大学 用作药物肠溶包衣材料的水溶性丙烯酸系树脂乳液的制备方法
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
CN101902996B (zh) 2007-10-15 2014-11-26 阿尔扎公司 芬太尼的一天更换一次透皮施用
CA2711774C (en) 2008-01-28 2016-05-24 Teikoku Seiyaku Co., Ltd. Fentanyl-containing patch for external use
KR20090101579A (ko) * 2008-03-24 2009-09-29 조선대학교산학협력단 펜타닐을 함유한 경피 흡수제
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
EP2596071B1 (en) * 2010-07-21 2019-02-13 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
EP2759294B1 (en) 2011-09-22 2017-11-01 Samyang Biopharmaceuticals Corporation Formulation for percutaneous administration containing Fentanyl and analague thereof
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2788573T3 (es) * 2012-09-28 2020-10-21 Nitto Denko Corp Preparación de parche que contiene óxido de amina
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
EP3185826B1 (en) * 2014-08-25 2020-08-19 Henkel IP & Holding GmbH Acrylic polymers and their use in transdermal drug delivery
CN107106552A (zh) * 2014-12-19 2017-08-29 3M创新有限公司 包含芬太尼的透皮药物递送装置
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3350554A4 (en) * 2015-09-18 2019-06-12 Slantrange, Inc. SYSTEMS AND METHOD FOR DETERMINING STATISTICS OF PLANT STOCKS BASED ON OPTICAL OVERHEAD MEASUREMENTS
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102134265B1 (ko) 2016-05-19 2020-07-15 미쯔비시 케미컬 주식회사 매크로 단량체 공중합체 및 그의 제조 방법
JPWO2019022249A1 (ja) * 2017-07-28 2020-07-09 国立大学法人九州大学 ミノキシジルの放出が制御された経皮吸収組成物
US20200297654A1 (en) 2017-10-17 2020-09-24 Lubrizol Advanced Materials, Inc. Composition and device for delivery of active agents to skin surfaces
WO2019194871A1 (en) * 2018-04-05 2019-10-10 Erbst Steven Robert Therapeutic elastic bandage for modulating the endocannabinoid system
WO2020009685A1 (en) 2018-07-02 2020-01-09 John Tang Transdermal dosage form
WO2020008366A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
EP3997138A4 (en) * 2019-07-11 2023-02-22 Henkel AG & Co. KGaA ACRYLIC POLYMER AND ADHESIVE COMPOSITIONS
DE102019120403A1 (de) 2019-07-29 2021-02-04 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System
CN111471126A (zh) * 2020-03-23 2020-07-31 杭州鹿扬科技有限公司 皮肤用粘贴材料及其制备方法
JP2022122784A (ja) * 2021-02-10 2022-08-23 コスメディ製薬株式会社 酸化防止剤含有経皮吸収製剤
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US12560526B1 (en) * 2022-08-30 2026-02-24 Florida A&M University System of and method for assessing surface energy impact of probes on adhesive properties

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA677797A (en) 1955-11-18 1964-01-14 Minnesota Mining And Manufacturing Company Sheet material having a pressure-sensitive adhesive coating of acrylate ester copolymer
US3352708A (en) * 1964-03-02 1967-11-14 Ball Brothers Co Inc Glass having dual protective coatings thereon and method for forming such coatings
US3900610A (en) * 1973-04-09 1975-08-19 Monsanto Co Process of making a pressure sensitive adhesive article
US3886126A (en) * 1973-04-09 1975-05-27 Monsanto Co Solutions of pressure-sensitive resin solutions with improved viscosity and flow
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4693776A (en) 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4732808A (en) 1985-11-14 1988-03-22 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive sheet material
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5820876A (en) * 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US4876249A (en) * 1987-01-12 1989-10-24 Rajadhyaksha Vithal J Compositions and method comprising heterocyclic compounds containing two heteroatoms
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4900555A (en) * 1987-02-26 1990-02-13 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5364630A (en) * 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5223262A (en) * 1989-02-23 1993-06-29 University Of Utah Transdermal delivery system utilizing one way membranes
US5162315A (en) * 1989-05-08 1992-11-10 Rajadhyaksha Vithal J Penetration enhancers
CA2065311C (en) * 1989-09-08 2000-01-11 Chia-Ming Chiang Solid matrix system for transdermal drug delivery
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5352456A (en) * 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
US5239714A (en) * 1992-08-12 1993-08-31 Huang Ming T Playpen structure
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DK0695177T3 (da) * 1993-04-20 1998-09-28 Hexal Ag Plaster indeholdende aktivt stof
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
ATE194281T1 (de) 1994-09-14 2000-07-15 Minnesota Mining & Mfg Matrix für transdermale wirkstofffreisetzung
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5505958A (en) * 1994-10-31 1996-04-09 Algos Pharmaceutical Corporation Transdermal drug delivery device and method for its manufacture
CN1170360A (zh) * 1994-12-21 1998-01-14 瑟垃技术有限公司 具有粘性贴面和剥离密封圆片的经皮输送系统
US5614210A (en) * 1995-03-31 1997-03-25 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of alfuzosin
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US6093419A (en) * 1995-06-07 2000-07-25 Lectec Corporation Compliance verification method and device in compulsory drug administration
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19527925C2 (de) * 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
US5900198A (en) * 1996-01-31 1999-05-04 Hori; Yasunori Method of producing molded resin product
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
JP3836566B2 (ja) * 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
EP0934078B1 (en) * 1996-10-24 2002-12-18 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
IT1286768B1 (it) 1996-11-15 1998-07-17 Alfredo Cecchini Lettino da sole girevole
US5998911A (en) * 1996-11-26 1999-12-07 Ngk Insulators, Ltd. Vibrator, vibratory gyroscope, and vibration adjusting method
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
EP0979072B1 (en) * 1997-02-28 2005-04-27 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of testosterone
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
GB9714650D0 (en) 1997-07-11 1997-09-17 Strakan Ltd Block copolymer
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
NZ509618A (en) * 1998-08-20 2003-09-26 3M Innovative Properties Co A patch-in-a-bottle that provides a fluid composition, which is applied to a surface and subsequently dries to form a covering, such as a patch
EP1061900B2 (en) 1999-01-14 2008-07-09 Noven Pharmaceuticals, Inc. Dermal compositions
DE60045153D1 (de) * 1999-04-13 2010-12-09 Hisamitsu Pharmaceutical Co Zubereitungen zur perkutanen absorption
KR20010036685A (ko) * 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
US6164190A (en) * 1999-12-16 2000-12-26 Tien Lin; Yu Mei Tea infusing device
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
JP5354763B2 (ja) * 2001-03-16 2013-11-27 アルザ・コーポレーシヨン フェンタニルを投与するための経皮的張り付け剤
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
AU2003210417B2 (en) * 2002-03-06 2007-10-11 Hexal Ag Transdermal system comprising fentanyl
WO2003090729A1 (en) * 2002-04-23 2003-11-06 Alza Corporation Transdermal analgesic systems with reduced abuse potential
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
DE10252725A1 (de) * 2002-11-13 2004-06-03 Lts Lohmann Therapie-Systeme Ag Feuchtigkeitsaktivierbare Klebstoffe für medizinische Anwendungszwecke
CN1909892A (zh) * 2003-10-30 2007-02-07 阿尔扎公司 具有降低的滥用可能性的透皮止痛剂系统
JP4745747B2 (ja) * 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery

Similar Documents

Publication Publication Date Title
JP2009185061A5 (enExample)
JP2012153772A5 (enExample)
JP2009292868A5 (enExample)
JP2013511594A5 (enExample)
JP2014508810A5 (enExample)
JP2017125195A5 (enExample)
JP2015503513A5 (enExample)
JP2004513890A5 (enExample)
JP2014533757A5 (enExample)
JP2011515203A5 (enExample)
JP2013521383A5 (enExample)
JP2009530444A5 (enExample)
JP2011523650A5 (enExample)
DE602004000408D1 (de) Druckempfindlicher Kleber und druckempfindliches Klebeprodukt
JP2012514075A5 (enExample)
EP2492330A3 (en) Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
ATE517161T1 (de) Druckempfindliches haftmittel mit hoher scherung
JP2012510564A5 (enExample)
JP2005511794A5 (enExample)
JP2013163782A5 (enExample)
JP2010519388A5 (enExample)
JP2013537526A5 (enExample)
JP2018506613A5 (enExample)
JP2014520171A5 (enExample)
JP2020516741A5 (enExample)